Insiders · Profile

Curley Joanne

Chief Development Officer at Vera Therapeutics. Filing since 31 May 2022. CIK 0001857670

Company
Date
Role
Action
Shares
Amount
Of holding
21 Aug 2023
Chief Development Officer
Sold on a plan
1,490
$24.82K
5.2%
16 Dec 2022
Chief Development Officer
Sold, plan not stated
2,212
$43.12K
7.6%
13 Dec 2022
Chief Development Officer
Sold, plan not stated
12,811
$234.05K
32.3%
12 Dec 2022
Chief Development Officer
Sold, plan not stated
6,900
$125.92K
20.5%
7 Dec 2022
Chief Development Officer
Sold, plan not stated
494
$8.14K
1.8%
17 Nov 2022
Chief Development Officer
Sold, plan not stated
3,289
$52.13K
10.7%
9 Nov 2022
Chief Development Officer
Sold, plan not stated
494
$8.17K
1.8%
18 Oct 2022
Chief Development Officer
Sold, plan not stated
8,590
$166.73K
23.6%
5 Oct 2022
Chief Development Officer
Sold, plan not stated
988
$21.38K
3.4%
21 Sep 2022
Chief Development Officer
Sold, plan not stated
1,174
$25.12K
3.9%
20 Sep 2022
Chief Development Officer
Sold, plan not stated
15,666
$323.82K
35.2%
7 Sep 2022
Chief Development Officer
Sold, plan not stated
988
$18.41K
3.3%
22 Aug 2022
Chief Development Officer
Sold, plan not stated
1,630
$30.76K
5.2%
19 Aug 2022
Chief Development Officer
Sold, plan not stated
6,909
$132.62K
18.8%
3 Aug 2022
Chief Development Officer
Sold, plan not stated
988
$16.61K
5.4%
19 Jul 2022
Chief Development Officer
Sold, plan not stated
11,444
$183.27K
38.5%
14 Jul 2022
Chief Development Officer
Sold, plan not stated
9,104
$137.86K
33.3%
7 Jul 2022
Chief Development Officer
Sold, plan not stated
9,666
$145.45K
31.5%
22 Jun 2022
Chief Development Officer
Sold, plan not stated
1,545
$23.20K
6.1%
17 Jun 2022
Chief Development Officer
Sold, plan not stated
5,887
$88.57K
19.7%
31 May 2022
Chief Development Officer
Sold, plan not stated
400
$6.09K
1.6%
21 decisions on file.